As delayed marriage and childbearing become increasingly common, many intended parents considering surrogacy are paying closer attention to their fertility indicators when planning a family. One of the most concerning findings on a fertility report is a low AMH level, which often leaves people feeling anxious and uncertain about their reproductive future.
What Is AMH and Why Is It Important?
AMH, or Anti-Müllerian Hormone, is a hormone secreted by small ovarian follicles. It primarily reflects the number of remaining follicles in the ovaries and is considered one of the most important indicators for evaluating a woman's ovarian reserve. Unlike many other reproductive hormones, AMH levels remain relatively stable and are not significantly affected by the menstrual cycle or daily hormonal fluctuations, making the test reliable at any time.
How to Interpret AMH Levels
In general, younger women typically have AMH levels above 2.0 ng/mL. Higher values usually indicate a greater ovarian reserve. An AMH level below 1.5 may suggest declining ovarian reserve, while levels below 1.0 warrant closer attention. For intended parents over the age of 35, lower AMH levels are relatively common. However, a low AMH result does not mean fertility opportunities are completely lost. Instead, it indicates that the number of eggs available for fertility treatment may be limited.
In a Mexico surrogacy journey, intended parents provide the embryos while the surrogate carries the pregnancy. AMH levels are primarily used to assess ovarian reserve and the potential success of embryo creation. Physicians evaluate AMH alongside age, hormone profiles, and other fertility assessments to determine whether it is appropriate to begin a treatment cycle.
The Practical Impact of Low AMH in Surrogacy
A low AMH level mainly reflects a reduced quantity of eggs rather than a complete loss of egg quality. With a personalized ovarian stimulation protocol, it is still possible to retrieve viable eggs even when ovarian reserve is diminished. During the Mexico surrogacy process, intended parents can first create embryos and then transfer them to a carefully screened surrogate. This approach helps overcome some of the limitations associated with the intended mother's uterus or ovarian function, providing greater flexibility in family-building plans.
How Intended Parents Can Respond to Low AMH
For individuals with low AMH levels, lifestyle optimization can play a supportive role. Maintaining a regular sleep schedule, following a balanced diet, engaging in moderate exercise, and managing stress may help slow the decline of ovarian reserve. At the same time, a comprehensive fertility evaluation—including hormone testing, antral follicle count assessment, and genetic counseling—can provide a clearer roadmap for a Mexico surrogacy journey.
Fertility assessment is an important starting point for family planning. Understanding indicators such as AMH can help intended parents approach the surrogacy process with greater confidence and clarity.
Power Fertility Clinic is a fully licensed reproductive medical center in Mexico operating under U.S. FDA standards and managed directly by an American fertility services team. Located in the heart of Mexico City, just 500 meters from the U.S. Embassy, Power IVF offers a wide range of fertility solutions, including egg donation, sperm donation, and third-party reproduction services, combined with advanced U.S. IVF technology to support individuals and couples facing age-related fertility challenges. The clinic features high-precision laboratory facilities and extensive expertise in IVF-PGT (PGT-A) and embryo screening, achieving industry-leading success rates. Mexican regulations support fertility treatment for single individuals, married couples, and LGBTQ families, while also allowing the international transport of frozen reproductive tissues. Power IVF is licensed to receive frozen egg samples from the United States, helping make your path to parenthood smoother and more accessible.
